A Phase 4 interventional study of atorvastatin and placebo in Endothelium and Hydroxymethylglutaryl-CoA Reductase Inhibitors, sponsored by Sun Yat-sen University. Status unknown. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-05-15.
Sponsored by Sun Yat-sen University · Phase 4, Interventional, and Prevention
Healthy subjects take single dose of 80mg atorvastatin, then measured their circulating endothelial microparticles and flow-mediated vasodilation in the brachial artery by ultrasound at different time points.
Sun Yat-sen University is the lead sponsor of 1,644 studies on the registry; 602 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
atorvastatin 20mg tablet, single dose of 80mg by mouth
Drug: atorvastatin
placebo 20mg tablet, single dose of 80mg by mouth
Drug: placebo
Also known as: Liptor
Also known as: sugar pill manufactured to mimic atorvastatin 20mg tablet
change of circulating endothelial microparticles
Time frame: from 1h to 24h after taking atorvastatin
No study locations are listed for this record.
This study is status unknown, as verified in May 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sun Yat-sen University